Bijal Shah

28PUBLICATIONS
252CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursImmunology not elsewhere classifiedPhysiotherapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 03, 2026
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma.

|Jul 17, 2026
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

|Jul 15, 2026
An unanchored matching-adjusted indirect comparison of the efficacy of zanubrutinib versus ibrutinib for the treatment of relapsed/refractory mantle-cell lymphoma.

|Jun 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

|Jun 04, 2026
CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.

|Jun 03, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

Pageof 5

Frequent Collaborators

8 joint publications

Aaron C Logan

6 joint publications

Gregory W Roloff

6 joint publications

Lori S Muffly

5 joint publications

Taiga Nishihori